QuiVad

Home / Funds / Keel Capital S.A., Sicav-Sif – Foghorn X2

Keel Capital S.A., Sicav-Sif – Foghorn X2

The short positions this fund discloses today, across every market.

Follow

This fund discloses no open short position today.

History of disclosures

155 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
September 27, 2019Cellavision ABSweden0.00%still open
September 26, 2019Bilia ABSweden0.00%still open
September 26, 2019Byggmax Group ABSweden0.00%still open
September 23, 2019Bilia ABSweden0.58%still open
September 22, 2019Bilia ABSweden0.58%still open
September 5, 2019Recipharm AB (publ)Sweden0.00%still open
September 2, 2019Byggmax Group ABSweden0.51%still open
September 1, 2019Byggmax Group ABSweden0.51%still open
August 26, 2019Byggmax Group ABSweden0.69%still open
August 26, 2019Recipharm AB (Publ)Sweden0.57%still open
August 25, 2019Byggmax Group ABSweden0.69%still open
August 25, 2019Recipharm AB (publ)Sweden0.57%still open
August 15, 2019Cellavision ABSweden0.50%still open
August 14, 2019Bilia ABSweden0.65%still open
August 14, 2019Cellavision ABSweden0.50%still open
August 13, 2019Bilia ABSweden0.65%still open
August 12, 2019Byggmax Group ABSweden0.75%still open
August 11, 2019Byggmax Group ABSweden0.75%still open
August 5, 2019Recipharm AB (Publ)Sweden0.69%still open
August 4, 2019Recipharm AB (publ)Sweden0.69%still open
August 2, 2019Bilia ABSweden0.79%still open
August 1, 2019Byggmax Group ABSweden0.88%still open
August 1, 2019Bilia ABSweden0.79%still open
August 1, 2019Skistar AktiebolagSweden0.63%August 1, 2019
August 1, 2019Cellavision ABSweden0.00%still open
July 31, 2019Byggmax Group ABSweden0.88%still open
July 31, 2019Skistar AktiebolagSweden0.63%still open
July 26, 2019Byggmax Group ABSweden0.97%still open
July 25, 2019Byggmax Group ABSweden1.05%still open
July 24, 2019Byggmax Group ABSweden1.05%still open
July 18, 2019Raysearch Laboratories AB (publ)Sweden0.00%still open
July 16, 2019Bilia ABSweden0.86%still open
July 15, 2019Bilia ABSweden0.86%still open
July 15, 2019Raysearch Laboratories AB (Publ)Sweden0.67%still open
July 14, 2019Raysearch Laboratories AB (publ)Sweden0.67%still open
July 10, 2019Bilia ABSweden0.90%still open
July 9, 2019Bilia ABSweden0.90%still open
July 9, 2019Recipharm AB (Publ)Sweden0.75%still open
July 9, 2019Raysearch Laboratories AB (Publ)Sweden0.70%still open
July 9, 2019Investment AB öresundSweden0.50%still open
July 8, 2019Byggmax Group ABSweden1.21%still open
July 8, 2019Raysearch Laboratories AB (Publ)Sweden0.80%still open
July 8, 2019Recipharm AB (publ)Sweden0.75%still open
July 8, 2019Investment AB öresundSweden0.50%still open
July 7, 2019Byggmax Group ABSweden1.21%still open
July 7, 2019Raysearch Laboratories AB (publ)Sweden0.80%still open
July 5, 2019Cellavision ABSweden0.51%still open
July 4, 2019Byggmax Group ABSweden1.11%still open
July 4, 2019Recipharm AB (Publ)Sweden0.82%still open
July 4, 2019Skistar AktiebolagSweden0.70%still open

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Keel Capital S.A., Sicav-Sif – Foghorn X2, data as at September 27, 2019, https://www.quivad.com/detenteur/keel-capital-s-a-sicav-sif-foghorn-x2